|
1
|
Cao S, Zeng Z, Wang X, Bin J, Xu D and
Liao Y: Pravastatin slows the progression of heart failure by
inhibiting the c-Jun N-terminal kinase-mediated intrinsic apoptotic
signaling pathway. Mol Med Rep. 8:1163–1168. 2013.
|
|
2
|
Sun JM, Wang CM, Guo Z, Hao YY, Xie YJ, Gu
J and Wang AL: Reduction of isoproterenol-induced cardiac
hypertrophy and modulation of myocardial connexin43 by a KATP
channel agonist. Mol Med Rep. 11:1845–1850. 2015.
|
|
3
|
Wang N, Cao Y and Zhu Y: Netrin-1 prevents
the development of cardiac hypertrophy and heart failure. Mol Med
Rep. 13:2175–2181. 2016.
|
|
4
|
Pereira SB, Velloso MW, Chermont S,
Quintão MM, Abdhala R Nunes, Giro C, Oliveira E, Alves T, Camacho
V, De Fátima Maia Contarato L, Pena FM, et al: β-adrenergic
receptor polymorphisms in susceptibility, response to treatment and
prognosis in heart failure: Implication of ethnicity. Mol Med Rep.
7:259–265. 2013.
|
|
5
|
Yu J, Yang S, Wang X and Gan R: Matrine
improved the function of heart failure in rats via inhibiting
apoptosis and blocking β3adrenoreceptor/endothelial nitric oxide
synthase pathway. Mol Med Rep. 10:3199–3204. 2014.
|
|
6
|
Liggett SB, Tepe NM, Lorenz JN, Canning
AM, Jantz TD, Mitarai S, Yatani A and Dorn GW II: Early and delayed
consequences of beta(2)-adrenergic receptor overexpression in mouse
hearts: Critical role for expression level. Circulation.
101:1707–1714. 2000. View Article : Google Scholar
|
|
7
|
Perez J Mialet, Rathz DA, Petrashevskaya
NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB, et al:
Beta 1-adrenergic receptor polymorphisms confer differential
function and predisposition to heart failure. Nat Med. 9:1300–1305.
2003. View Article : Google Scholar
|
|
8
|
Xiao RP, Zhu W, Zheng M, Chakir K, Bond R,
Lakatta EG and Cheng H: Subtype-specific beta-adrenoceptor
signaling pathways in the heart and their potential clinical
implications. Trends Pharmacol Sci. 25:358–365. 2004. View Article : Google Scholar
|
|
9
|
Zaugg M, Xu W, Lucchinetti E, Shafiq SA,
Jamali NZ and Siddiqui MA: Beta-adrenergic receptor subtypes
differentially affect apoptosis in adult rat ventricular myocytes.
Circulation. 102:344–350. 2000. View Article : Google Scholar
|
|
10
|
Xiao RP, Cheng H, Zhou YY, Kuschel M and
Lakatta EG: Recent advances in cardiac beta(2)-adrenergic signal
transduction. Circ Res. 85:1092–1100. 1999. View Article : Google Scholar
|
|
11
|
Hanft LM and McDonald KS: Sarcomere length
dependence of power output is increased after PKA treatment in rat
cardiac myocytes. Am J Physiol Heart Circ Physiol. 296:H1524–H1531.
2009. View Article : Google Scholar :
|
|
12
|
Fredriksson JM, Lindquist JM, Bronnikov GE
and Nedergaard J: Norepinephrine induces vascular endothelial
growth factor gene expression in brown adipocytes through a
beta-adrenoreceptor/cAMP/protein kinase a pathway involving src but
independently of Erk1/2. J Biol Chem. 275:13802–13811. 2000.
View Article : Google Scholar
|
|
13
|
Tirziu D, Chorianopoulos E, Moodie KL,
Palac RT, Zhuang ZW, Tjwa M, Roncal C, Eriksson U, Fu Q, Elfenbein
A, et al: Myocardial hypertrophy in the absence of external stimuli
is induced by angiogenesis in mice. J Clin Invest. 117:3188–3197.
2007. View
Article : Google Scholar :
|
|
14
|
Heineke J, Auger-Messier M, Xu J, Oka T,
Sargent MA, York A, Klevitsky R, Vaikunth S, Duncan SA, Aronow BJ,
et al: Cardiomyocyte GATA4 functions as a stress-responsive
regulator of angiogenesis in the murine heart. J Clin Invest.
117:3198–3210. 2007. View
Article : Google Scholar :
|
|
15
|
Lee JC, Kim IH, Cho GS, Park JH, Ahn JH,
Yan BC, Kwon HM, Kim YM, Cheon SH, Cho JH, et al: Ischemic
preconditioning-induced neuroprotection against transient cerebral
ischemic damage via attenuating ubiquitin aggregation. J Neurol
Sci. 336:74–82. 2014. View Article : Google Scholar
|
|
16
|
Dorn GW II, Tepe NM, Lorenz JN, Koch WJ
and Liggett SB: Low- and high-level transgenic expression of
beta2-adrenergic receptors differentially affect cardiac
hypertrophy and function in Galphaq-overexpressing mice. Proc Natl
Acad Sci USA. 96:pp. 6400–6405. 1999; View Article : Google Scholar :
|
|
17
|
Du XJ, Autelitano DJ, Dilley RJ, Wang B,
Dart AM and Woodcock EA: beta(2)-adrenergic receptor overexpression
exacerbates development of heart failure after aortic stenosis.
Circulation. 101:71–77. 2000. View Article : Google Scholar
|
|
18
|
Du XJ, Gao XM, Jennings GL, Dart AM and
Woodcock EA: Preserved ventricular contractility in infarcted mouse
heart overexpressing beta (2)-adrenergic receptors. Am J Physiol
Heart Circ Physiol. 279:H2456–H2463. 2000.
|
|
19
|
Endoh M: Force-frequency relationship in
intact mammalian ventricular myocardium: Physiological and
pathophysiological relevance. Eur J Pharmacol. 500:73–86. 2004.
View Article : Google Scholar
|
|
20
|
Engelhardt S, Hein L, Dyachenkow V,
Kranias EG, Isenberg G and Lohse MJ: Altered calcium handling is
critically involved in the cardiotoxic effects of chronic
beta-adrenergic stimulation. Circulation. 109:1154–1160. 2004.
View Article : Google Scholar
|
|
21
|
Foerster K, Groner F, Matthes J, Koch WJ,
Birnbaumer L and Herzig S: Cardioprotection specific for the G
protein Gi2 in chronic adrenergic signaling through beta
2-adrenoceptors. Proc Natl Acad Sci USA. 100:pp. 14475–14480. 2003;
View Article : Google Scholar :
|
|
22
|
Petrashevskaya N, Gaume BR, Mihlbachler
KA, Dorn GW II and Liggett SB: Bitransgenesis with
beta(2)-adrenergic receptors or adenylyl cyclase fails to improve
beta(1)-adrenergic receptor cardiomyopathy. Clin Transl Sci.
1:221–227. 2008. View Article : Google Scholar
|
|
23
|
Xu Q, Jennings NL, Sim K, Chang L, Gao XM,
Kiriazis H, Lee YY, Nguyen MN, Woodcock EA, Zhang YY, et al:
Pathological hypertrophy reverses β2-adrenergic receptor-induced
angiogenesis in mouse heart. Physiol Rep. 3:pii: e123402015.
View Article : Google Scholar
|
